BTAI
Bioxcel Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.97 / 10
Underperform
The fundamental profile is weak, with a score of 3.0/10. Key revenue metrics show significant year-over-year declines (-79.68%), while the interest coverage ratio is only 15.48%, indicating limited financial flexibility. Although some balance-sheet factors score positively, they are outweighed by the negative trends, leading to an overall underperform rating.
Analysis Checks(6/10)
Revenue-MV
Value-3.62
Score1/3
Weight9.28%
1M Return4.24%
Value-3.62
Score1/3
Weight9.28%
1M Return4.24%
Days sales outstanding
Value45.82
Score2/3
Weight2.01%
1M Return1.10%
Value45.82
Score2/3
Weight2.01%
1M Return1.10%
Net income-Revenue
Value-0.17
Score2/3
Weight18.46%
1M Return8.45%
Value-0.17
Score2/3
Weight18.46%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.84%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.84%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight13.17%
1M Return5.75%
Value-0.50
Score0/3
Weight13.17%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value-79.68
Score1/3
Weight-1.35%
1M Return-0.79%
Value-79.68
Score1/3
Weight-1.35%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight18.44%
1M Return8.45%
Value0.46
Score2/3
Weight18.44%
1M Return8.45%
PB-ROE
Value-0.73
Score3/3
Weight25.00%
1M Return12.83%
Value-0.73
Score3/3
Weight25.00%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value-79.68
Score1/3
Weight-1.30%
1M Return-0.76%
Value-79.68
Score1/3
Weight-1.30%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight18.13%
1M Return8.41%
Value-0.07
Score2/3
Weight18.13%
1M Return8.41%
Revenue-MV
Value-3.62
Score1/3
Weight9.28%
1M Return4.24%
Value-3.62
Score1/3
Weight9.28%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value-79.68
Score1/3
Weight-1.35%
1M Return-0.79%
Value-79.68
Score1/3
Weight-1.35%
1M Return-0.79%
Days sales outstanding
Value45.82
Score2/3
Weight2.01%
1M Return1.10%
Value45.82
Score2/3
Weight2.01%
1M Return1.10%
Profit-MV
Value0.46
Score2/3
Weight18.44%
1M Return8.45%
Value0.46
Score2/3
Weight18.44%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight18.46%
1M Return8.45%
Value-0.17
Score2/3
Weight18.46%
1M Return8.45%
PB-ROE
Value-0.73
Score3/3
Weight25.00%
1M Return12.83%
Value-0.73
Score3/3
Weight25.00%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.84%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.84%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-79.68
Score1/3
Weight-1.30%
1M Return-0.76%
Value-79.68
Score1/3
Weight-1.30%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight13.17%
1M Return5.75%
Value-0.50
Score0/3
Weight13.17%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight18.13%
1M Return8.41%
Value-0.07
Score2/3
Weight18.13%
1M Return8.41%
Is BTAI fundamentally strong?
- BTAI scores 2.97/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -9070.61% net margin, -0.58 P/E ratio, -0.33 P/B ratio, and 71.44% earnings growth, these metrics solidify its Underperform investment rating.
